Caring for older patients with cancer during the COVID-19 pandemic: A Young International Society of Geriatric Oncology (SIOG) global perspective
- PMID: 32402764
- PMCID: PMC7252080
- DOI: 10.1016/j.jgo.2020.05.001
Caring for older patients with cancer during the COVID-19 pandemic: A Young International Society of Geriatric Oncology (SIOG) global perspective
Abstract
The ongoing coronavirus disease 2019 (COVID-19) pandemic has affected millions of people in over 180 territories, causing a significant impact on healthcare systems globally. Older adults, as well as people living with cancer, appear to be particularly vulnerable to COVID-19 related morbidity and mortality, which means that older adults with cancer are an especially high-risk population. This has led to significant changes in the way geriatric oncologists provide care to older patients, including the implementation of novel methods for clinical visits, interruptions or delays in procedures, and modification of therapeutic strategies, both in the curative and palliative settings. In this manuscript, we provide a global overview of the perspectives of geriatric oncology providers from countries across Europe, America, and Asia, regarding the adaptive strategies utilized to continue providing high quality care for older patients with cancer during the COVID-19 pandemic. Through these perspectives, we attempt to show that, although each country and setting has specific issues, we all face similar challenges when providing care for our older patients with cancer during these difficult times.
Keywords: COVID-19; Delivery of healthcare; Global health; Older adults; Pandemics.
Copyright © 2020. Published by Elsevier Ltd.
Conflict of interest statement
Declaration of Competing Interest Dr. Battisti has received travel grants and speaker fees from Pfizer and travel grants from Genomic Health. Dr. Loh serves as a consultant to Pfizer and Seattle Genetics. Dr. Loh is supported by the Wilmot Research Fellowship Award and National Cancer Institute (K99CA237744). Dr. Neuendorff has received honoraria and travel support by Janssen-Cilag, Medac, and Jazz Pharmazeutical. Dr. Mian reports Honoraria/Consultancy fees from Amgen, Celgene, Takeda, Janssen, Sanofi. All other authors have no financial conflicts of interest to disclose.
Figures
References
-
- WHO . 2020. COVID-19 Dashboard. https://covid19.who.int/ [accessed 22 April 2020]
-
- Ferlay J., Ervik M., Lam F. 2018. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today. [accessed 22 April 2020]
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
